Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK7 | P50613 | 16/20 | 1.00 |
| ▸ | CDK2 | P24941 | 13/20 | 1.00 |
| ▸ | CCNE1 | P24864 | 8/20 | 1.00 |
| ▸ | CCNH | P51946 | 8/20 | 1.00 |
| ▸ | MNAT1 | P51948 | 7/20 | 1.00 |
| ▸ | CDK1 | P06493 | 7/20 | 1.00 |
| ▸ | CDK9 | P50750 | 7/20 | 1.00 |
| ▸ | CDK4 | P11802 | 4/20 | 1.00 |
| ▸ | CDK6 | Q00534 | 4/20 | 1.00 |
| ▸ | CDK5 | Q00535 | 4/20 | 1.00 |
| ▸ | CDK8 | P49336 | 3/20 | 1.00 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.56 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.56 |
| ▸ | CCND1 | P24385 | 2/20 | 0.56 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.56 |
| ▸ | INSRR | P14616 | 1/20 | 0.56 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.56 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ct-7001 SCHEMBL17032274 | 1.00 | CDK7 (1.00) | CDK7CDK2CCNE1CCNHMNAT1 | |
| Ct-7001 SCHEMBL31249484 | 1.00 | CDK7 (1.00) | CDK7CDK2CCNE1CCNHMNAT1 | |
| Ct-7001 SCHEMBL20848165 | 1.00 | CDK7 (1.00) | CDK7CDK2CCNE1CCNHMNAT1 | |
| Ct-7001 SCHEMBL18298190 | 0.99 | CDK7 (0.98) | CDK7CDK2CCNE1CCNHMNAT1 | |
| SCHEMBL24791459 | 0.95 | CDK7 (0.91) | CDK7CDK2CCNE1CCNHMNAT1 | |
| SCHEMBL17032283 | 0.93 | CDK7 (0.88) | CDK7CDK2CCNE1CCNHMNAT1 | |
| Hydrochloric Acid SCHEMBL18298199 | 0.93 | CDK7 (0.86) | CDK7CDK2CCNE1CCNHMNAT1 | |
| SCHEMBL24964842 | 0.92 | CDK7 (0.85) | CDK7CDK2CCNE1CCNHMNAT1 | |
| SCHEMBL30209065 | 0.92 | CDK7 (0.85) | CDK7CDK2CCNE1CCNHMNAT1 | |
| SCHEMBL24964839 | 0.92 | CDK7 (0.85) | CDK7CDK2CCNE1CCNHMNAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230000870-A1 | METHODS OF TREATING CANCER IN BIOMARKER-IDENTIFIED PATIENTS WITH INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2023-01-05 | — | — | US | disclosed |
| US-9932344-B2 | Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2018-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230000870-A1 | METHODS OF TREATING CANCER IN BIOMARKER-IDENTIFIED PATIENTS WITH INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | CDK7, RB1, MKI67 | CDK7 1/4885CDK2 20/4885CCNE1 54/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.